Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q4 Loss, Beats Revenue Estimates

分组1 - Maravai LifeSciences Holdings, Inc. reported a quarterly loss of $0.04 per share, better than the Zacks Consensus Estimate of a loss of $0.07, and improved from a loss of $0.06 per share a year ago, resulting in an earnings surprise of +40.03% [1] - The company posted revenues of $49.87 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 1.21%, but down from $56.56 million in the same quarter last year [2] - Maravai LifeSciences shares have underperformed the market, losing about 4% since the beginning of the year compared to the S&P 500's gain of 0.7% [3] 分组2 - The current consensus EPS estimate for the coming quarter is -$0.05 on revenues of $57.61 million, and for the current fiscal year, it is -$0.22 on revenues of $210.65 million [7] - The Zacks Industry Rank for Medical - Products is in the bottom 44% of over 250 Zacks industries, indicating that the industry outlook can significantly impact stock performance [8]